Increases in Local Violence Tied to Higher Subsequent Suicide Rates
By Lori Solomon HealthDay Reporter
Medically reviewed by Drugs.com

FRIDAY, Aug. 1, 2025 -- At the county level, increases in homicide rates are linked to higher suicide rates the following year, according to a study published online July 29 in Social Science & Medicine.
Noting that suicide remains a leading cause of death in the United States, with rates increasing during the past twenty years, Daniel C. Semenza, Ph.D., from Rutgers University in Camden, New Jersey, and colleagues analyzed the longitudinal relationship between homicide and suicide rates across U.S. counties from 1968 to 2019. The authors focused on variations by race, firearm involvement, and urbanicity. The analysis included 162,472 county-year observations from the CDC WONDER database and the National Historical Geographic Information System.
The researchers found that higher homicide rates predicted subsequent increases in suicide rates one year later, particularly for firearm-related fatalities. For each one-unit increase in the total homicide rate, there was an associated 0.493-unit increase in total suicide rates. Among White populations and in rural areas, the homicide-suicide relationship was stronger.
"Interpersonal and self-directed violence are interconnected and should be treated as such," Semenza said in a statement. "Local violence doesn't only harm the victims -- it destabilizes entire communities in ways that increase the risk of suicide. Violence prevention is suicide prevention."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-02 12:00
Read more

- Remotely Delivered Behavioral Intervention Reduces Systolic BP Variation
- COVID-19 Linked To Asthma, Seasonal Allergies
- U.S. Resident Diagnosed With Rare Screwworm Parasite After Travel
- Lilly's Oral GLP-1, Orforglipron, is Successful in Third Phase 3 Trial, Triggering Global Regulatory Submissions This Year for the Treatment of Obesity
- FDA Suspends U.S. License of Chikungunya Vaccine
- Green Spaces Provided Pandemic Protection Against Depression, Study Says
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions